Link between glycemic control and family support among Nigerians with type 2 diabetes mellitus

In the current issue of Family Medicine and Community Health (Volume 6, Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0115, Nnenna A. Osuji, Oluwaseun Solomon Ojo, Sunday O. Malomo, Peter T. Sogunle, Ademola O. Egunjobi and Olufisayo O. Odebunmi of the Family Medicine Department, Federal Medical Centre, Abeokuta, Nigeria describe how Nigeria and other sub-Saharan African countries are currently experiencing a rapid increase in the incidence of noncommunicable diseases, especially diabetes mellitus (DM), as a result of increasing urbanization and changing lifestyles.

People with diseases such as DM that require lifelong management may be tired of taking medications and adhering to the lifestyle modifications over time. This underscores the importance of motivation in people with DM. The authors consider whether support from the family can motivate people with DM to improve self-management behaviors and ultimately their glycemic control? Few studies have looked at the relationship between perceived family support and glycemic control among people with type 2 DM.

Source: http://fmch-journal.org/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study warns women with type 2 diabetes against using oral estrogen therapy